MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations
Translational Lung Cancer Research · 2024-04 · 13 (4) · 940-946
DOI: 10.21037/tlcr-24-98 ↗Kurz gefasst
Editorial in der Zeitschrift Translational Lung Cancer Research, 2024-04. Verfasst von Jan Trøst Jørgensen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Sciences, Dx-Rx Institute, Fredensborg, Denmark. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Sciences, Dx-Rx Institute, Fredensborg, Denmark.
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Pathology Division, Agilent Technologies Denmark ApS, Glostrup, Denmark.
ORCID-Profile: Jan Trøst Jørgensen, Edyta M Urbanska, Jens Mollerup
Zitieren
APA
Jørgensen, J. T., Urbanska, E. M., & Mollerup, J. (2024). MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations. Translational Lung Cancer Research, 13(4), 940-946. https://doi.org/10.21037/tlcr-24-98
Vancouver
Jørgensen JT, Urbanska EM, Mollerup J. MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations. Translational Lung Cancer Research. 2024;13(4):940-946. doi:10.21037/tlcr-24-98
BibTeX
@article{Jrgensen2024,
author = {Jørgensen, Jan Trøst and Urbanska, Edyta M and Mollerup, Jens},
title = {MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations},
journal = {Translational Lung Cancer Research},
year = {2024},
volume = {13},
number = {4},
pages = {940--946},
doi = {10.21037/tlcr-24-98}
}
EUVIMED